Indivior Pharmaceuticals (INDV) has announced the pricing of its offering of $450M in convertible senior notes due in 2031. The offering size was increased from an initial amount of $400M.

CRISPR Therapeutics AG (Nasdaq: CRSP) (the “Company”) today announced the pricing of $550 million aggregate principal amount ...

Duke Energy (DUK) announced the pricing of $1.3 billion in convertible senior notes due in 2029 through a private placement. This amount is higher than the previously stated $1 billion. The initial ...

The notes will be senior, unsecured obligations of Indivior and will accrue interest at a rate of 0.625% per annum, payable semi-annually in arrears on March 15 and September 15 of each year, ...

BTCS Inc. announces $10 million convertible notes issuance at a 198% premium, part of its DeFi/TradFi funding strategy. BTCS Inc. has announced the issuance of approximately $10 million in convertible ...

CRISPR Therapeutics (CRSP) upsized a $550M convertible notes deal due 2031 at 1.125%, with a 45% conversion premium—get the key terms now.

Super Micro Computer (NASDAQ:SMCI) announced Tuesday that it has priced the $2 billion convertible senior notes due 2030. The stock recovered some losses Tuesday after a 9.7% fall on Monday, when the ...

PAR Technology Corporation (NYSE:PAR) shares fell 10.4% Friday after the company priced a private offering of $250.0 million in 4.00% Convertible Senior Notes due ...

Dave ( (DAVE)) has shared an update. On March 4 and 5, 2026, Dave Inc. entered into a purchase agreement and announced the pricing of a private offering of $175 million aggregate principal amount of 0 ...

GameStop boosts its convertible note offering to $2.7 billion, potentially for a Bitcoin allocation under its updated investment policy. Today, GameStop Corp. (NYSE: GME) filed a Form 8-K with the SEC ...